Canada· CA-DIN-01934791
ROBAXISAL C 1/2
A codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04) product containing codeine phosphate + acetylsalicylic acid + methocarbamol, registered in Canada by GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC. The same ATC class is registered in 3 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04) is registered in 3 of 19 countries.
Countries holding a registration under ATC N02AA59 (codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04)), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 2 of them publish a price we can compare per daily dose
Codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04) · ATC N02AA59
3 / 19 countries
- Belgiumprice
- Canada
- Polandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CODEINE PHOSPHATE + ACETYLSALICYLIC ACID + METHOCARBAMOL
- Manufacturer
- GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
- Country
- Canada (CA)
- ATC code
- N02AA59
- ATC class
- Codein, Kombinationen exkl. Psycholeptika (Codein Monopräparate siehe R05DA04)
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04).
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04) · interactions on record
4 records
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N02AA59
Codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04), as other registers publish it.
- BelgiumAlgocod 500 mg - 30 mgLaboratoires S.M.B.
- PolandEfferalgan CodeineUPSA SAS
- PolandEfferalgan CodeineMedezin Sp. z o.o.
- PolandEfferalgan CodeinePharmaVitae Sp. z o.o. sp. k.
- PolandEfferalgan CodeineInPharm Sp. z o.o.
- PolandEfferalgan CodeineDelfarma Sp. z o.o.
- PolandEfferalgan CodeinePharmapoint SA
- BelgiumPanadol Codéine 500 mg - 30 mgHaleon Belgium
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/451ee90f-7b8d-4e19-8f93-2a11b4c52ef8 GET /v1/drugs/451ee90f-7b8d-4e19-8f93-2a11b4c52ef8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "01934791",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N02AA59",
"schedule": [
"Narcotic (CDSA I)"
],
"drug_code": "12946",
"strengths": [
"32.4 MG",
"325 MG",
"400 MG"
],
"ahfs_class": null,
"substances": [
"CODEINE PHOSPHATE",
"ACETYLSALICYLIC ACID",
"METHOCARBAMOL"
],
"product_categorization": null
}See everything about codein, kombinationen exkl. psycholeptika (codein monopräparate siehe r05da04).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.